0001807983-24-000001.txt : 20240514 0001807983-24-000001.hdr.sgml : 20240514 20240514154245 ACCESSION NUMBER: 0001807983-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 EFFECTIVENESS DATE: 20240514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medicenna Therapeutics Corp. CENTRAL INDEX KEY: 0001807983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-513257 FILM NUMBER: 24943886 BUSINESS ADDRESS: STREET 1: 2 BLOOR ST W., 7TH FLOOR CITY: TORONTO STATE: A6 ZIP: M4W 3E2 BUSINESS PHONE: 416 648-5555 MAIL ADDRESS: STREET 1: 2 BLOOR ST W., 7TH FLOOR CITY: TORONTO STATE: A6 ZIP: M4W 3E2 D 1 primary_doc.xml X0708 D LIVE 0001807983 Medicenna Therapeutics Corp. 2 BLOOR ST W., 7TH FLOOR TORONTO A6 ONTARIO, CANADA M4W 3E2 +1 (604) 671-6673 CANADA (FEDERAL LEVEL) A2 Acquisition Corp. None Corporation true Fahar Merchant 2 Bloor St W. 7th Floor Toronto A6 ONTARIO, CANADA M4W 3E2 Executive Officer Director David Hyman 2 Bloor St W. 7th Floor Toronto A6 ONTARIO, CANADA M4W 3E2 Executive Officer Rosemina Merchant 2 Bloor St W. 7th Floor Toronto A6 ONTARIO, CANADA M4W 3E2 Executive Officer Albert Beraldo 2 Bloor St W. 7th Floor Toronto A6 ONTARIO, CANADA M4W 3E2 Director Karen Dawes 2 Bloor St W. 7th Floor Toronto A6 ONTARIO, CANADA M4W 3E2 Director John Geltosky 2 Bloor St W. 7th Floor Toronto A6 ONTARIO, CANADA M4W 3E2 Director John Sampson 2 Bloor St W. 7th Floor Toronto A6 ONTARIO, CANADA M4W 3E2 Director Biotechnology Decline to Disclose 06b false 2024-04-30 true true true true true The Company issued 5,141,388 pre-funded warrants to acquire common shares at an exercise price of CDN$0.01 (US$0.007275) per common share until exercised in full. false 0 14587404 14550000 37404 U.S. dollar amounts based on the Bank of Canada average rate of exchange reported on April 30, 2024, which was CDN$1.3746 =US$1.00. false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Medicenna Therapeutics Corp. /s/ Fahar Merchant Fahar Merchant President & CEO 2024-05-14